Clinical Takeaway CBD at low doses administered short-term did not significantly improve glucose tolerance or alter gut microbiome composition in sedentary overweight or obese adults, despite theoretical mechanisms suggesting potential benefit. This...
Cannabidiol Glucose Tolerance Study Evidence Based
Clinical Takeaway In sedentary adults with overweight or obesity, a short course of low-dose CBD did not produce measurable improvements in glucose tolerance or changes to gut bacteria composition. These findings do...
Endocannabinoid System Research: CBD Glucose Study
Clinical Takeaway CBD supplementation at low doses for a short duration did not improve glucose tolerance or alter gut microbiota composition in overweight or obese adults, despite theoretical mechanisms suggesting potential benefit....
Cannabidiol Glucose Tolerance Effects in Obesity
Clinical Takeaway Clinical Takeaway: In this pilot study of overweight and sedentary adults, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance or alter the gut microbiome composition compared...
`Cannabidiol & Glucose Tolerance: Clinical Trial Findings`
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...
Cannabidiol & Glucose Tolerance: Clinical Trial Evidence
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance or meaningfully alter the gut microbiome in sedentary adults with overweight or obesity. While animal studies and...
Cannabidiol & Glucose Tolerance: Clinical Research Findings
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, alter gut microbiome composition, or reduce inflammation in sedentary adults with overweight or obesity. While animal research...
Cannabidiol & Glucose Tolerance: Clinical Evidence Review
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not measurably improve glucose tolerance or beneficially alter the gut microbiome in sedentary adults with overweight or obesity. While animal research...
Research Digest: 20 Recent Studies – March 18, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81...
Cannabidiol & Glucose Tolerance: Clinical Research Review
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...